Breast Cancer Trial, Recruiting NCT00437879 Sponsor: Sunnybrook Health Sciences Centre Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT00437879
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with breast cancer (stage I to IV) through a tissue or cell sample, have not yet had any first-line treatment, and are planned to receive chemotherapy before surgery (with or without radiation therapy)
  • People whose cancer can be measured by ultrasound or MRI, with that scan done within 28 days before starting treatment
  • People who are generally able to carry out daily activities with little to no limitation, as measured by a standard medical scale called the ECOG scale (score of 0 or 1) (confirm with trial site)
  • People with a life expectancy of at least 6 months
  • People whose blood test results, taken within 7 days before starting treatment, show that the bone marrow, liver, and kidneys are functioning well enough to meet the trial's required levels (confirm with trial site for specific values)
  • People who are able to understand and are willing to sign a written consent form before any trial-related procedures take place

Who may not be able to join:

  • People who have had chemotherapy, radiation therapy, or major surgery within 4 weeks before joining the trial, or who have not yet recovered from side effects of earlier treatments
  • People who are currently taking part in another clinical trial involving an experimental treatment
  • People who have cancer that has spread to the brain
  • People who have a history of allergic reactions to medicines with a similar chemical or biological makeup to the trial drug (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gregory J. Czarnota, Ph.D. M.D., Sunnybrook Health Sciences Centre

Phone: 416-480-5329

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
17 December 2008
Est. completion
1 June 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

The primary Outcome will be correlate changes in ultrasound backscatter parameters obtained throughout the course of treatment with pathological complete, partial, or complete and partial response.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov